The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease (Q34541695)

2 August 2017

1 reference

title

The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease (English)

1 reference

2 August 2017

Joshua J Ofman

1

1 reference

2 August 2017

G H Dorn

series ordinal

2

1 reference

2 August 2017

M B Fennerty

series ordinal

3

1 reference

2 August 2017

R Fass

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Alimentary Pharmacology & Therapeutics

2 August 2017

1 reference

2 August 2017

16

1 reference

2 August 2017

2

1 reference

2 August 2017

261-273

1 reference

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

The impact of gastroesophageal reflux disease on health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Heartburn treatment in primary care: randomised, double blind study for 8 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Symptoms in gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Heartburn requiring frequent antacid use may indicate significant illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Clinical esophageal pH recording: a technical review for practice guideline development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

On-demand treatment of gastro-oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Meta-analysis of the effect of placebo on the outcome of medically treated reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01167.X

10.1046/J.1365-2036.2002.01167.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference